1
Jun 2026
Researchers from the Icahn School of Medicine at Mount Sinai have uncovered the first direct evidence that deep brain stimulation (DBS) can remodel white matter pathways in the brain and alter communication across large-scale neural networks, revealing a previously unrecognized mechanism that may explain how the therapy helps patients recover from severe depression.
1
Jun 2026
Three-quarters of people who respond well to the newest types of biologics for psoriasis can safely reduce their dosage, often even by half.
1
Jun 2026
People who vape regularly show altered activity in 3,124 genes across the genome compared with people who do not smoke or vape.
1
Jun 2026
Pediatric research leaders identified 10 high-promise areas likely to shape child health over the next 5 to 10 years, including genomics, mental health, vaccines, artificial intelligence, perinatal medicine, precision therapeutics, health equity, nutrition, environmental health, and cancer treatment. The paper argues that these opportunities will only translate into better outcomes if pediatric research receives sustained funding, public trust, workforce support, advocacy, and equitable implementation.
1
Jun 2026
The DNA changes responsible for a rare genetic condition causing babies to be born without a pancreas can now be identified in almost all affected children through genetic testing.
1
Jun 2026
A newly developed portable, point-of-care PET technology can image any organ, delivering high-quality results to guide interventional procedures.
1
Jun 2026
Di Wang, PhD, and Y. Shrike Zhang, PhD, of the Division of Engineering in the Mass General Brigham Department of Medicine, are the lead and senior authors of a paper published in Nature Biomedical Engineering, "4D-printed adaptive hydrogel tissue expanders for ear and breast reconstruction."
1
Jun 2026
A novel PET imaging framework reveals that bariatric surgery impacts not only body weight, but also the metabolic function of multiple organs.
1
Jun 2026
A new PET tracer targeting carbonic anhydrase IX (CAIX) has demonstrated exceptional sensitivity and high tumor-to-background contrast in detecting clear cell renal cell carcinoma (ccRCC), according to early clinical research.
1
Jun 2026
Could the way doctors traditionally measure obesity allow a subset of people with obesity-related health risks slip through the cracks?
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
